序贯器官衰竭评估(SOFA)-2评分制定的依据与方法学:共识声明
该共识声明由60名重症医学与流行病学专家参与,代表65个国家,通过会议、德尔菲过程和明确规则,结合系统评价与Meta分析证据,制定了SOFA-2评分。SOFA-2保留了原SOFA的6个器官系统生理变量,部分类别更名(中枢神经系统改为脑、肾改为肾脏、凝血改为止血、肝改为肝脏),修订了器官支持药物和设备变量以反映当前实践,并为实验室数据或器官支持不可及或非适应的情况添加了替代变量。部分切点阈值根据系统评价和数据分析证据进行了修改。变量在10个代表性数据库共334万患者中进行了2次验证,评估分布和预测效度(ICU出院时死亡率)。胃肠道和免疫两个额外器官系统因数据不足、复杂性或缺乏内容与预测效度而未能制定评分。
要点
- SOFA-2由60名专家、65个国家参与制定,通过德尔菲过程和明确规则形成,在334万患者中验证。
- SOFA-2保留原SOFA的6个器官系统生理变量,部分类别更名:中枢神经系统改为脑、肾改为肾脏、凝血改为止血、肝改为肝脏。
- 修订了器官支持药物和设备变量以反映当前实践,部分切点阈值根据系统评价和数据分析证据修改。
- 为实验室数据或器官支持不可及(如低资源环境)或非适应(如治疗上限)的情况添加了替代变量。
- 胃肠道和免疫两个器官系统因数据不足、复杂性或缺乏内容与预测效度未能制定评分。
适用人群与场景
- 需要重症监护的成人患者。
诊断标准与关键阈值
- SOFA-2对单个器官系统功能障碍进行0至4分分级,生理变量位于原SOFA的6个器官系统内,部分类别更名(中枢神经系统改为脑、肾改为肾脏、凝血改为止血、肝改为肝脏),部分切点阈值根据系统评价和数据分析证据修改。
研究设计与关键结果
- 共识声明通过会议、德尔菲过程和明确规则制定,结合系统评价与Meta分析数据合成,变量在10个代表性数据库共334万患者中进行了2次验证,评估分布和预测效度(ICU出院时死亡率)。
- 60名专家参与,其中18名(30%)为女性;代表65个国家,其中33个(51%)来自欧洲和中亚,13个(20%)来自北美,8个(12%)来自拉丁美洲和加勒比地区。
证据类型、等级与局限
- 证据类型:共识声明,基于系统评价、Meta分析和数据分析,并在10个数据库共334万患者中验证。
- 胃肠道和免疫两个器官系统因数据不足、复杂性或缺乏内容与预测效度而未能制定评分。
对床旁实践的改变
- SOFA-2提供了更新后的器官功能障碍定义和可量化标准,用于对成人重症患者单个器官系统功能障碍程度进行分级,考虑了患者管理和结局的当代变化。
指南或共识出处
- SOFA-2共识声明(JAMA Netw Open)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: The Sequential Organ Failure Assessment (SOFA) score was published in 1996 to describe organ dysfunction in critically ill adult patients in a readily quantifiable and sequential manner. Considerable changes have occurred over the last 3 decades in the use of organ support drugs and devices and in patient outcomes, necessitating revision of the score.
OBJECTIVES: To develop definitions of organ dysfunction that reflect current understanding and to identify representative variables to generate a revised SOFA score (SOFA-2) of individual organ dysfunction.
EVIDENCE REVIEW: A task force of experts in intensive care medicine and epidemiology generated definitions of organ dysfunction, identified relevant variables (physiological and laboratory data specific to the organ system, pharmacological and mechanical organ support), and proposed a 0 to 4-point grading of dysfunction severity through meetings, Delphi processes, and explicit rules, informed by data synthesis, including systematic reviews and meta-analysis. Variables were tested in 2 validation exercises using separate datasets totaling 3.34 million patients within 10 representative databases from diverse geographical and socioeconomic settings to assess distribution and predictive validity (mortality at intensive care unit discharge).
FINDINGS: A total of 60 experts participated, with 18 (30%) female participants. Overall, 65 countries were represented, with 33 (51%) from Europe and Central Asia, 13 (20%) from North America; and 8 (12%) from Latin America and the Caribbean. The physiological variables within the 6 organ systems used in the original SOFA score were retained, although some categories were renamed (ie, central nervous system was changed to brain, renal to kidney, coagulation to hemostasis, and hepatic to liver). Revisions of organ support drug and device variables were made to reflect current practice. Alternative variables were added for instances when laboratory data and/or organ support interventions would be inaccessible (eg, in some low-resource settings) or not indicated (eg, ceiling of treatment). Some point cutoff thresholds were modified based on evidence from systematic reviews and data analyses. Scores could not be developed for 2 additional organ systems (gastrointestinal and immune) due to insufficient data, complexity, or lack of content and predictive validity for the variables assessed. Explicit rules were developed to facilitate scoring consistency.
CONCLUSIONS AND RELEVANCE: Through a methodologically robust development process, the SOFA-2 score offers updated definitions to describe organ dysfunction in adult patients requiring critical care and readily quantifiable criteria to grade the degree of dysfunction in individual organ systems. This score considers contemporaneous changes in patient management and outcomes.
参考来源
- Moreno R, Rhodes A, Ranzani O, et al. Rationale and Methodological Approach Underlying the Development of the Sequential Organ Failure Assessment (SOFA)-2 Score: A Consensus Statement. JAMA Netw Open. 2025. PMID: 41159829. doi:10.1001/jamanetworkopen.2025.45040
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。